AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Chemed Corporation
Video analysis: CHE
All videosNo video analysis for this stock yet. Request one from our team.
News: CHE
Amundi Has $25.08 Million Holdings in Chemed Corporation $CHE
Amundi increased its position in Chemed Corporation (NYSE: CHE) by 51.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 53,856 shares of the company's stock after purchasing an additional 18,301 shares during the period. Amundi owned about 0.41% of Chemed worth $25,083,000 at the
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m.
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.
CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Bank of New York Mellon Corp Acquires Shares of 94,045 Chemed Corporation $CHE
Bank of New York Mellon Corp acquired a new position in shares of Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 94,045 shares of the company's stock, valued at approximately $43,800,000. Bank of New York Mellon Corp owned approximately
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
16,747 Shares in Chemed Corporation $CHE Purchased by Deutsche Bank AG
Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,747 shares of the company's stock, valued at approximately $7,800,000. Deutsche Bank AG owned about 0.13% of Chemed
Similar companies
-
Option Care Health, Inc.
OPCH
·
NASDAQ
Compare
-
Stevanato Group S.p.A.
STVN
·
New York Stock Exchange
Compare
-
DaVita Inc.
DVA
·
New York Stock Exchange
Compare
-
BrightSpring Health Services, Inc. Common Stock
BTSG
·
NASDAQ
Compare
-
AptarGroup, Inc.
ATR
·
New York Stock Exchange
Compare
-
Teleflex Incorporated
TFX
·
New York Stock Exchange
Compare